Cargando…

Syndecan-4 in Tumor Cell Motility

SIMPLE SUMMARY: Cell migration is crucial fReaor metastasis formation and a hallmark of malignancy. The primary cause of high mortality among oncology patients is the ability of cancer cells to metastasize. To form metastasis, primary tumor cells must be intrinsically able to move. The transmembrane...

Descripción completa

Detalles Bibliográficos
Autores principales: Keller-Pinter, Aniko, Gyulai-Nagy, Szuzina, Becsky, Daniel, Dux, Laszlo, Rovo, Laszlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268284/
https://www.ncbi.nlm.nih.gov/pubmed/34282767
http://dx.doi.org/10.3390/cancers13133322
_version_ 1783720322152792064
author Keller-Pinter, Aniko
Gyulai-Nagy, Szuzina
Becsky, Daniel
Dux, Laszlo
Rovo, Laszlo
author_facet Keller-Pinter, Aniko
Gyulai-Nagy, Szuzina
Becsky, Daniel
Dux, Laszlo
Rovo, Laszlo
author_sort Keller-Pinter, Aniko
collection PubMed
description SIMPLE SUMMARY: Cell migration is crucial fReaor metastasis formation and a hallmark of malignancy. The primary cause of high mortality among oncology patients is the ability of cancer cells to metastasize. To form metastasis, primary tumor cells must be intrinsically able to move. The transmembrane, heparan sulfate proteoglycan syndecan-4 (SDC4) exhibits multiple functions in signal transduction by regulating Rac1 GTPase activity and consequently actin remodeling, as well as regulating focal adhesion kinase, protein kinase C-alpha and the level of intracellular calcium. By affecting several signaling pathways and biological processes, SDC4 is involved in cell migration under physiological and pathological conditions as well. In this review, we discuss the SDC4-mediated cell migration focusing on the role of SDC4 in tumor cell movement. ABSTRACT: Syndecan-4 (SDC4) is a ubiquitously expressed, transmembrane proteoglycan bearing heparan sulfate chains. SDC4 is involved in numerous inside-out and outside-in signaling processes, such as binding and sequestration of growth factors and extracellular matrix components, regulation of the activity of the small GTPase Rac1, protein kinase C-alpha, the level of intracellular calcium, or the phosphorylation of focal adhesion kinase. The ability of this proteoglycan to link the extracellular matrix and actin cytoskeleton enables SDC4 to contribute to biological functions like cell adhesion and migration, cell proliferation, cytokinesis, cellular polarity, or mechanotransduction. The multiple roles of SDC4 in tumor pathogenesis and progression has already been demonstrated; therefore, the expression and signaling of SDC4 was investigated in several tumor types. SDC4 influences tumor progression by regulating cell proliferation as well as cell migration by affecting cell-matrix adhesion and several signaling pathways. Here, we summarize the general role of SDC4 in cell migration and tumor cell motility.
format Online
Article
Text
id pubmed-8268284
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82682842021-07-10 Syndecan-4 in Tumor Cell Motility Keller-Pinter, Aniko Gyulai-Nagy, Szuzina Becsky, Daniel Dux, Laszlo Rovo, Laszlo Cancers (Basel) Review SIMPLE SUMMARY: Cell migration is crucial fReaor metastasis formation and a hallmark of malignancy. The primary cause of high mortality among oncology patients is the ability of cancer cells to metastasize. To form metastasis, primary tumor cells must be intrinsically able to move. The transmembrane, heparan sulfate proteoglycan syndecan-4 (SDC4) exhibits multiple functions in signal transduction by regulating Rac1 GTPase activity and consequently actin remodeling, as well as regulating focal adhesion kinase, protein kinase C-alpha and the level of intracellular calcium. By affecting several signaling pathways and biological processes, SDC4 is involved in cell migration under physiological and pathological conditions as well. In this review, we discuss the SDC4-mediated cell migration focusing on the role of SDC4 in tumor cell movement. ABSTRACT: Syndecan-4 (SDC4) is a ubiquitously expressed, transmembrane proteoglycan bearing heparan sulfate chains. SDC4 is involved in numerous inside-out and outside-in signaling processes, such as binding and sequestration of growth factors and extracellular matrix components, regulation of the activity of the small GTPase Rac1, protein kinase C-alpha, the level of intracellular calcium, or the phosphorylation of focal adhesion kinase. The ability of this proteoglycan to link the extracellular matrix and actin cytoskeleton enables SDC4 to contribute to biological functions like cell adhesion and migration, cell proliferation, cytokinesis, cellular polarity, or mechanotransduction. The multiple roles of SDC4 in tumor pathogenesis and progression has already been demonstrated; therefore, the expression and signaling of SDC4 was investigated in several tumor types. SDC4 influences tumor progression by regulating cell proliferation as well as cell migration by affecting cell-matrix adhesion and several signaling pathways. Here, we summarize the general role of SDC4 in cell migration and tumor cell motility. MDPI 2021-07-01 /pmc/articles/PMC8268284/ /pubmed/34282767 http://dx.doi.org/10.3390/cancers13133322 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Keller-Pinter, Aniko
Gyulai-Nagy, Szuzina
Becsky, Daniel
Dux, Laszlo
Rovo, Laszlo
Syndecan-4 in Tumor Cell Motility
title Syndecan-4 in Tumor Cell Motility
title_full Syndecan-4 in Tumor Cell Motility
title_fullStr Syndecan-4 in Tumor Cell Motility
title_full_unstemmed Syndecan-4 in Tumor Cell Motility
title_short Syndecan-4 in Tumor Cell Motility
title_sort syndecan-4 in tumor cell motility
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268284/
https://www.ncbi.nlm.nih.gov/pubmed/34282767
http://dx.doi.org/10.3390/cancers13133322
work_keys_str_mv AT kellerpinteraniko syndecan4intumorcellmotility
AT gyulainagyszuzina syndecan4intumorcellmotility
AT becskydaniel syndecan4intumorcellmotility
AT duxlaszlo syndecan4intumorcellmotility
AT rovolaszlo syndecan4intumorcellmotility